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Atherosclerosis commonly involves the vessels of the
aortic arch, particularly at their origins. Proximal sub-
clavian artery stenosis is frequently associated with
reversed flow in the vertebral artery. The reversed flow,
stolen from the brain perfusion, can cause cerebrovas-
cular ischemic symptoms, which may be precipitated
or aggravated by exercise of the ipsilateral arm. In the
past, such stenosis was corrected using a transthoracic
approach. In 1969, Crawford et al [1] reported their
initial series of 62 revascularizations of the innominate
and subclavian arteries using transthoracic bypass
grafting or endarterectomy. Although the therapeutic
efficacy was satisfactory, the initial operative mortality
rates of this and subsequent series ranged from 6% to
19% [2–4]. In 1967, the carotid–subclavian bypass was
introduced by Dietrich et al [5]. The operative mortal-
ity rate of the extrathoracic approach was 4.8%, with
symptom resolution in 93% of 125 patients. Extra-
thoracic bypass using a polytetrafluoroethylene (PTFE)
graft is the procedure we recommend to treat subcla-
vian steal syndrome because of its lower morbidity,
lower mortality and greater technical simplicity.
CASE PRESENTATIONS
Case 1
A 66-year-old male had been suffering from dizzi-
ness and syncope while exercising with his left arm
over the past 2–3 years. He had smoked cigarettes for
many years. Hypertension and diabetes mellitus were
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Arterial occlusive disease of the arch vessels is often associated with flow reversal in the vertebral
artery of such patients, the so-called subclavian steal syndrome. We treated two such cases that were
diagnosed based on symptoms, physical examination and angiography. In the first case, the occlu-
sive lesion was found at the origin of left subclavian artery, while the occlusion was positioned at
the origin of innominate artery in the second case. A carotid–subclavian and a carotid–carotid bypass
using 8-mm PTFE grafts were performed, respectively. No complications were noted and the patients
have retained a symptom-free status during a follow-up of 5 years. Taking into account the expense
of stenting and the patency rate, extrathoracic bypass surgery using a PTFE graft for the treatment
of orifice occlusive lesions of arch vessels is cheaper and has an overall better patency rate. Further-
more, because it is the final choice of treatment after percutaneous transluminal angioplasty fails, it
should be considered as an ideal therapy for lesions at the origin of arch vessels.
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also present. The patient denied a history of coronary
artery disease (CAD). On auscultation, no carotid bruit
was audible. Diminished pulsation of the left radial
artery was detectable on palpation. The blood pres-
sure of the left arm was lower than that of the right
arm (right, 117/66 mmHg; left, 102/67 mmHg). Total
occlusion of the left subclavian artery at its orifice and
reversal of flow in the left vertebral artery were dem-
onstrated by angiography (Figure 1). A left carotid–
subclavian bypass using an 8-mm PTFE graft was
performed and took less than 1.5 hours. The symptoms
and signs of subclavian steal syndrome disappeared.
No cerebrovascular accident or other complications
developed postoperatively. An angiography was per-
formed 6 months later. No reversed vertebral flow
was detected (Figure 2).
Case 2
An 80-year-old male had experienced dizziness and
fainting for many years. He had a past history of CAD
involving post coronary artery bypass grafting (CABG)
using the left internal mammary artery 2 years previ-
ously. A cigarette smoking habit that lasted for many
years was also noted. No angina developed after CABG
and good systolic function of the left ventricle was
demonstrated by echocardiography during postoper-
ative follow-up. A loud bruit on the anterior triangle
of the right neck could be heard. Pulsation of the right
radial artery was diminished and the blood pressure of
the right arm was lower than the left arm (right, 110/
60 mmHg; left, 149/57 mmHg). A marked narrowing
(> 90%) of the proximal innominate artery was noted
on angiography (Figure 3A). A carotid–carotid bypass
using an 8-mm PTFE graft was carried out in less
than 2 hours. The symptoms and signs disappeared
after the operation. When angiography was carried
out 2 months later, good patency of the graft was














Figure 1. (A) The left subclavian artery was not visible from its origin at the aorta, which indicates that there was total occlusion at the
orifice of the proximal left subclavian artery. (B) Delayed enhancement of the left vertebral artery indicates the presence of reverse flow




Figure 2. Reversed flow in the vertebral artery was not found
after a left carotid–subclavian arterial bypass using an 8-mm
PTFE graft was introduced.
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DISCUSSION
Subclavian steal syndrome, first described in 1960 by
Contorni [6], includes various cerebrovascular ischemic
symptoms, such as dizziness, unsteadiness, vertigo,
visual changes, which are caused by the stealing of
brain perfusion from the vertebral artery. The stealing
is secondary to the occlusive disease of the proximal
innominate or subclavian arteries. A weak or absent
radial/ulnar pulse in the presence of an ipsilateral re-
duced blood pressure > 20 mmHg compared with the
contralateral arm suggests the presence of subclavian
steal syndrome [7]. A bruit may also be localizable to the
proximal subclavian artery.
The management of occlusive disease that involves
the innominate or subclavian arteries has advanced
considerably over the past four decades. Originally,
transthoracic repair of the stenosis was performed,
but the initial mortality rates were quite high (6–19%).
Despite a reduction in the mortality rates in recent
years, transthoracic repair is still associated with greater
mortality and morbidity compared with extrathoracic
bypass [8,9].
Carotid–subclavian bypass, carotid–subclavian
transposition, axilloaxillary bypass or percutaneous
transluminal angioplasty (PTA) are currently advo-
cated as the primary treatments for symptomatic sub-
clavian artery stenosis. In 1994, Vitti et al [10] reported
their experiences in extrathoracic reconstruction as a
treatment for subclavian steal syndrome. The patency
rates at 5 years and 10 years for carotid–subclavian
bypass were about 94%, which compares favorably
with the 66–89% patency rates for axilloaxillary bypass
surgery [11–13]. In 2000, AbuRahma et al [14] reported
their 20-year experience with carotid–subclavian by-
pass grafting using PTFE and the 1-, 3-, 5- and 10-year
patency rates were 100%, 98%, 96% and 92%, respec-
tively. Although carotid–subclavian transposition has
been reported to have a 7-year patency rate of 100% [15],
the potential aggravation of coronary ischemia during
the interruption to vertebral and internal mammary
artery blood flow is an obstacle to the use of this option.
Carotid–carotid artery bypass is most appropriate
when used for patients with occlusive disease of the
innominate artery. An internal shunt should be used to
maintain adequate brain perfusion during the opera-
tion. The graft is placed in a retrosternal position to
avoid any potential discomfort that might occur due
to graft pressure on the trachea or larynx [16].
There remains the choice between an autogenous
vein graft and a prosthetic graft. A survey of the avail-
able English literature on bypasses between the sub-
clavian and common carotid arteries reported a rate
of thrombosis for prosthetic graft bypasses of 1.3%
compared with 18.6% for vein graft bypasses [17]. 
In 1986, Ziomek et al [18] reported a statistically sig-
nificant advantage when prosthetic grafts were used












Figure 3. (A) There is a marked narrowing (> 90%) of the proximal innominate artery and delayed enhancement of the right vertebral
artery is present. (B) No reversed flow in the right vertebral artery was detectable after the carotid–carotid arterial bypass using an 8-mm
PTFE graft was carried out.
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between the common carotid artery and subclavian
artery. They also reviewed the available literature
and compiled data indicating long-term patency
rates of 97.0% and 74.6% for prosthetic and vein
grafts, respectively. The next question becomes one
of the choice of prosthetic graft material. Law et al
[19] reported that PTFE grafts show a patency of 95%,
which is followed by Dacron grafts with a patency of
84% and saphenous vein grafts with 65% patency.
These results may be related to certain features of the
PTFE graft material, such as low thrombogenicity,
their rapid incorporation into the host tissue, their
resistance to infection, their stable intima, their resist-
ance to kinking and their ability to maintain their
strength. PTFE graft material is a 60/20 Thru-pore
one-piece design. The 60-μm outer structure provides
quicker, more complete healing, and the 20-μm inner
structure can prevent blood leakage and control healing
(Figure 4) [20]. This design also provides strong resis-
tance to kinking and compression as well as tension-
free adjustment.
In 2007, AbuRahma et al [21] reported primary
patency rates at 1, 3 and 5 years of 100%, 98% and 96%
for carotid–subclavian bypasses using PTFE, com-
pared with 93%, 78% and 70% for the stent group,
respectively. Although many institutions choose PTA
with or without stenting as the initial therapy and it
has resulted in excellent technical success rates when
used on stenotic lesions, the technical success rates
range from only 50% to 72% in cases with near-total
occlusive lesions [22–25]. This lower success rate was
especially noticeable if the occlusive lesion was near
the orifice, where it is much more difficult to apply
PTA or stenting [26]. Clinically significant restenosis
can occur in up to 40% of cases by 4 years after stenting.
The high expense of a stent also makes it a less attrac-
tive treatment option.
Fainting and dizziness are common complaints in
clinical practice and subclavian steal syndrome should
be considered if the patient shows a blood pressure
difference > 20 mmHg (systolic) between the upper
extremities. If the occlusive lesion is near the orifice
of the arch vessels, an extrathoracic carotid–subclavian
bypass or a carotid–carotid bypass, both using PTFE
graft material, are recommended, as this is a cheaper
and technically simpler surgical intervention. This
approach also results in a better patency rate, partic-
ularly when used to treat senile patients or those with
complications.
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我們利用 8 厘米的 PTFE 人工血管分別施予頸動脈至左側鎖骨下動脈繞道及頸動脈至
頸動脈繞道手術。整個手術過程非常順利且沒有任何的併發症產生。兩位病患之症狀
於手術後追蹤五年皆不復見。相較於使用血管支架之昂貴花費，使用 PTFE 人工血管
於胸腔外繞道手術，既可以避免胸骨鋸開之後遺症，又可減少醫療支出，同時也是經
皮氣球擴張術失敗後的理想治療方式。
關鍵詞：頸動脈至頸動脈繞道手術，頸動脈至左側鎖骨下動脈繞道手術，胸腔外動脈繞道手術，
PTFE 人工血管，鎖骨下動脈竊流症候群
(高雄醫誌 2008;24:536–41)
